Lifestyle interventions for cancer survivors

Author(s):  
Desiree Rivers
2020 ◽  
Vol 14 (6) ◽  
pp. 155798832094544
Author(s):  
Dalnim Cho ◽  
Karen Basen-Engquist ◽  
Chiara Acquati ◽  
Curtis Pettaway ◽  
Hilary Ma ◽  
...  

Although a number of lifestyle interventions have been developed for cancer survivors, the extent to which they are effective for African American men with cancer is unclear. Given that African American men have the highest prostate cancer burden and the lack of proven interventions, this study developed a culturally-tailored lifestyle intervention for African American men with prostate cancer and their partners that aimed to improve healthy lifestyle behaviors (physical activity and healthy eating) and quality of life. The aim of the present study is to provide a detailed overview of the model-based process of intervention adaptation. Based on the IM Adapt approach (Highfield et al., 2015) and Typology of Adaptation (Davidson et al., 2013), the present study adapted existing, evidence-based interventions to address African American prostate cancer survivors’ and their partners’ potential unmet needs including anxiety/uncertainty about cancer progression, communication between partners, cultural sensitivity, and concordance/discordance of motivation and behaviors between partners. The intervention adaptation was a comprehensive and fluid process. To the best knowledge of the author, this is the first couple-based lifestyle intervention specifically developed for African American men with prostate cancer. The present study will be highly informative to future investigators by providing flexible and detailed information regarding lifestyle intervention adaptation for racial/ethnic minority men with prostate cancer and their partners.


2017 ◽  
Vol 35 (15_suppl) ◽  
pp. e17103-e17103
Author(s):  
Eirwen Murray Miller ◽  
Amerigo Rossi ◽  
David Samuel ◽  
Carolina Ramirez ◽  
Shankar Viswanathan ◽  
...  

e17103 Background: Endometrial cancer survivors are the least physically active of all cancer groups. In past feasibility studies of a physical activity intervention for obese endometrial cancer survivors, we have found high adherence and significant improvements in quality of life and body composition but low recruitment (48%). The primary objective of this study was to assess the acceptability the FitBit Alta activity tracker among socioculturally diverse endometrial cancer survivors. Methods: After IRB approval, patients were approached for study participation at the time of routine follow-up in gynecologic oncology clinic. Eligible patients included those with a history of stage I-IV endometrial cancer diagnosed within the past 10 years who were not undergoing active therapy at the time of study participation. Participants were instructed to wear a FitBit Alta for 30 days. At the conclusion of the study period, patients received a phone call to complete an acceptability questionnaire. After 30 days of use, the FitBits were returned to provide detailed daily activity data for the duration of the study period. Results: Of 37 eligible identified patients, 30 agreed to participate in the study (81%). Recruitment to this study was significantly higher as compared with our historical exercise lifestyle intervention (48%, p < 0.01). Mean age was 65 and BMI 33 kg/m2 (19-64kg/m2). 70% reported stage I and II disease. Patients self-identified as 53% white, 23% black, and 33% Hispanic. 40% of patients had household incomes < $60,000 per year. Preliminary data shows that patients walk between 2,500 and 12,000 steps per day. Conclusions: Recruitment to the FitBit Alta was significantly higher than historically reported exercise lifestyle interventions at our institution. Additional research is needed to understand retention and patient satisfaction with lifestyle interventions using wearable technology.


2021 ◽  
Vol 5 (Supplement_2) ◽  
pp. 967-967
Author(s):  
X Chen ◽  
C Chiu ◽  
HT Cheung ◽  
ME White ◽  
X Chen ◽  
...  

Abstract Objectives To establish the preferences and perceived barriers related to physical activity and diet programming of breast cancer survivors (BCS) to inform the development of Information and Communication Technology (ICT)-based lifestyle interventions. Methods This was a cross-sectional study of 197 BSC aged 18 years or older and diagnosed with ductal carcinoma in situ (DCIS) or Stage I-IV breast cancer. The BCS were recruited during routine oncology appointments at a Midwestern cancer center. A survey was conducted to query survivors’ level of interest in, preferences for, and perceived barriers to participating in an exercise and dietary intervention program, with a specific emphasis on ICT-based programming. Results Overall, 85% of BCS reported they would consider participating in exercise and diet intervention research. Approximately 45% of participants reported that they had received diet and/or exercise information as part of their cancer care. However, only 15% of the participants received such information from healthcare professionals with the appropriate expertise (e.g., Dietitian, Exercise Specialist). Over two-thirds of the participants reported frequent use of mobile devices and the internet, and 80% indicated comfort using these devices (e.g., tablet, smart phone). The top three preferred formats for an ICT-based diet and exercise intervention program were “website”, “mobile apps” and “e-mails”. Older participants (&gt;60 years) were more likely to report a preference for e-mails while younger participants (&lt;60 years) were more likely to report a preference for websites or mobile apps. The most common perceived barriers to participation in a lifestyle intervention included fatigue, family responsibility and work. Conclusions Most BCS in this study were interested in exercise and diet interventions and would be comfortable with an ICT-based format with a preference for delivery via websites, mobile apps or e-mails. Future ICT-based lifestyle interventions should be designed with consideration of BCS’ age, barriers, facilitators and other characteristics. Funding Sources USDA-NIFA Hatch Project 1,011,487


Nutrients ◽  
2021 ◽  
Vol 13 (11) ◽  
pp. 3730
Author(s):  
Maura Harrigan ◽  
Courtney McGowan ◽  
Annette Hood ◽  
Leah M. Ferrucci ◽  
ThaiHien Nguyen ◽  
...  

The use of dietary supplements is common in the general population and even more prevalent among cancer survivors. The World Cancer Research Fund/American Institute for Cancer Research specifies that dietary supplements should not be used for cancer prevention. Several dietary supplements have potential pharmacokinetic and pharmacodynamic interactions that may change their clinical efficacy or potentiate adverse effects of the adjuvant endocrine therapy prescribed for breast cancer treatment. This analysis examined the prevalence of self-reported dietary supplement use and the potential interactions with tamoxifen and aromatase inhibitors (AIs) among breast cancer survivors enrolled in three randomized controlled trials of lifestyle interventions conducted between 2010 and 2017. The potential interactions with tamoxifen and AIs were identified using the Natural Medicine Database. Among 475 breast cancer survivors (2.9 (mean) or 2.5 (standard deviation) years from diagnosis), 393 (83%) reported using dietary supplements. A total of 108 different types of dietary supplements were reported and 36 potential adverse interactions with tamoxifen or AIs were identified. Among the 353 women taking tamoxifen or AIs, 38% were taking dietary supplements with a potential risk of interactions. We observed a high prevalence of dietary supplement use among breast cancer survivors and the potential for adverse interactions between the prescribed endocrine therapy and dietary supplements was common.


2019 ◽  
Vol 9 ◽  
Author(s):  
Raheem J. Paxton ◽  
William Garner ◽  
Lorraine T. Dean ◽  
Georgiana Logan ◽  
Kristen Allen-Watts

2015 ◽  
Vol 139 (3) ◽  
pp. 546-552 ◽  
Author(s):  
Anke Smits ◽  
Alberto Lopes ◽  
Nagindra Das ◽  
Ruud Bekkers ◽  
Leon Massuger ◽  
...  

2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Renske Altena ◽  
Laila Hubbert ◽  
Narsis A. Kiani ◽  
Yvonne Wengström ◽  
Jonas Bergh ◽  
...  

Abstract Background Cancer treatment-related morbidity relevantly compromises health status in cancer survivors, and efforts to optimise health-related outcomes in this population are vital to maximising healthy survivorship. A pre-treatment assessment – and possibly preventive management strategies – of cancer patients at increased risk for cardiovascular disease (CVD) seems a rational approach in this regard. Definitive evidence for such strategies is largely lacking, thereby impeding the formulation of firm recommendations. Results The current scoping review aims to summarise and grade the evidence regarding strategies for prediction and prevention of CVD in adults in relation to oncological treatments. We conducted a scoping literature search for different strategies for primary prevention, such as medical and lifestyle interventions, as well as the use of predictive risk scores. We identified studies with moderate to good strength and up to now limited evidence to recommend primary preventive strategies in unselected patients treated with potentially cardiotoxic oncologic therapies. Conclusion Efforts to minimize the CVD burden in cancer survivors are needed to accomplish healthy survivorship. This can be done by means of robust models predictive for CVD events or application of interventions during or after oncological treatments. Up to now there is insufficient evidence to implement preventive strategies in an unselected group of patients treated with potential cardiotoxic oncological treatments. We conclude that randomised controlled trials are needed that evaluate medical and lifestyle interventions in groups at increased risk for complications, in order to be able to influence chronic illness risks, such as cardiovascular complications, for cancer survivors.


Sign in / Sign up

Export Citation Format

Share Document